Tirzepatide
A dual GIP and GLP-1 receptor agonist extensively studied in laboratory and animal models for appetite signaling, insulin-response pathways, lipid-metabolism markers, and glucose homeostasis. For laboratory and scientific research purposes only.
- Formula
- C225H348N48O68
- Molecular Weight
- 4,813.53 g/mol
- Amino Acids
- 39
- CAS Number
- 2023788-19-2
Concentration output for laboratory reference handling. Not dosing guidance.
For laboratory and scientific research purposes only. Not for human or animal consumption. This calculator does not provide dosing, protocol, or administration guidance.
- Tirzepatide once weekly for the treatment of obesityJastreboff AM, et al. · N Engl J Med · 2022 · PMID 35658024
- Dual GIP and GLP-1 receptor agonism in type 2 diabetesFrías JP, et al. · Lancet · 2021 · PMID 34186022
Complete the Stack
Curated Sets →Isolates which measured outcome belongs to which incretin receptor.
A triple receptor agonist studied in preclinical models for combined activity at GLP-1, GIP, and glucagon pathways. Investigated for potential effects on satiety signaling, glucose regulation, and energy-expenditure markers. For laboratory and scientific research purposes only.
A sterile diluent prepared with 0.9% benzyl alcohol, used in laboratory settings to reconstitute lyophilized reference compounds for in-vitro analysis. For laboratory and scientific research purposes only.